Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 8.59 | 5.22 | -30.35 | 64.64 | 70.01 | -60.17 | -227.87 | -7.77 | -71.93 | -11.79 | 49.43 | -9.54 | 99.66 | 97.61 | 84.99 | |
| Profit Margin | 3.23 | 3.57 | -34.52 | -4.20 | -5.87 | 47.88 | -299.29 | 41.70 | -91.04 | -10.13 | 17.73 | -63.89 | -21.29 | -43.14 | 88.32 | |
| Operating Margin | 1.78 | 0.84 | -34.35 | -4.85 | -8.00 | -52.80 | -226.08 | -8.87 | -70.66 | -15.51 | 43.82 | -37.37 | -34.15 | -54.73 | -56.57 | |
|
EPS Growth
|
120.29 | 21.43 | -835.29 | 82.40 | -27.27 | 492.86 | -401.82 | 135.54 | -298.31 | 76.07 | 564.29 | -280.39 | 66.31 | -110.13 | 196.69 | |
| EPS EUR | 14.00 | 17.00 | -125.00 | -22.00 | -28.00 | 110.00 | -332.00 | 118.00 | -234.00 | -56.00 | 260.00 | -469.00 | -158.00 | -332.00 | 321.00 | |
| Return on Assets (ROA) | 2.09 | 2.25 | -20.55 | -2.43 | -2.81 | 12.28 | -26.76 | 4.99 | -9.00 | -2.03 | 2.47 | -5.34 | -1.99 | -4.60 | 4.86 | |
| Return on Equity (ROE) | 2.76 | 2.94 | -27.96 | -4.83 | -4.83 | 16.11 | -32.44 | 7.12 | -11.43 | -2.41 | 5.21 | -11.44 | -3.91 | -8.63 | 7.57 | |
| Return on Invested Capital (ROIC) | 2.68 | 5.12 | -27.10 | -6.18 | -4.75 | -18.81 | -24.25 | -1.51 | -8.89 | -3.69 | 12.75 | -6.64 | -6.32 | -11.00 | 3.45 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 1.03 | 0.64 | 0.54 | 0.17 | 0.14 | 0.06 | 0.03 | 0.01 | - - | 0.14 | 0.42 | 0.52 | 0.52 | 0.46 | 0.22 | |
| Debt/Equity | 1.36 | 0.84 | 0.74 | 0.34 | 0.24 | 0.08 | 0.03 | 0.01 | - - | 0.17 | 0.88 | 1.10 | 1.02 | 0.87 | 0.34 | |
| Debt/EBITDA | -476.81 | -275.29 | 158.55 | -1,106.26 | 7,697.11 | 639.67 | 613.98 | 17,070.30 | 1,388.55 | 3,680.42 | -470.70 | 1,272.92 | 1,598.89 | 250.51 | -451.94 | |
|
Debt/Capitalization
|
1.34 | 0.83 | 0.73 | 0.34 | 0.23 | 0.08 | 0.03 | 0.01 | - - | 0.17 | 0.87 | 1.09 | 1.01 | 0.86 | 0.34 | |
| Long-Term Debt/Capitalization | 0.88 | 0.58 | 0.38 | 0.14 | 0.10 | 0.06 | 0.02 | - - | - - | - - | 0.68 | 0.86 | 0.74 | 0.58 | 0.18 | |
| Interest Debt per Share EUR | 0.10 | 0.12 | 0.10 | 0.02 | 0.02 | 0.01 | - - | - - | 0.02 | 0.05 | 0.46 | 0.60 | 0.59 | 0.44 | 0.17 | |
| Debt Growth | -12.81 | -16.11 | -29.64 | -53.77 | -2.96 | -57.51 | -31.14 | -45.22 | -85.71 | -100.00 | - - | 15.96 | -8.76 | -18.46 | -56.19 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 270.18 | 285.75 | 185.41 | 121.75 | 156.94 | 353.91 | 517.14 | 970.44 | 697.53 | 604.28 | 1,025.88 | 845.20 | 858.27 | 810.82 | 901.77 | |
| Quick Ratio | 253.24 | 271.78 | 176.94 | 117.31 | 154.11 | 333.86 | 488.05 | 960.31 | 694.82 | 602.23 | 1,025.01 | 839.77 | 852.96 | 798.30 | 875.75 | |
| Cash Ratio | 151.20 | 105.69 | 92.07 | 86.82 | 125.69 | 311.01 | 469.97 | 937.69 | 670.48 | 586.98 | 325.58 | 336.10 | 394.26 | 97.24 | 38.95 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | -100 | -100 | 200 | - - | - - | 500 | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 4,685.96 | 8,073.49 | 24,897.61 | 23,616.67 | 16,585.54 | 39,540.93 | 39,912.00 | 46,524.67 | 78,316.13 | 116,984.06 | 167,576.47 | 147,511.83 | 7.92 | 22.82 | 48.65 | |
| Receivables Turnover | 291.05 | 192.82 | 319.52 | 409.93 | 430.59 | 502.85 | 302.19 | 551.65 | 304.12 | 861.35 | 1,054.80 | 275.69 | 377.02 | 653.29 | 365.09 | |
| Payables Turnover | 562.44 | 527.06 | 691.75 | 218.07 | 140.64 | 370.28 | 439.98 | 447.22 | 463.69 | 474.55 | 299.85 | 305.67 | 1.21 | 9.06 | 26.73 | |
|
Asset Turnover
|
64.78 | 63.11 | 59.54 | 57.91 | 47.92 | 25.65 | 8.94 | 11.96 | 9.88 | 20.07 | 13.92 | 8.36 | 9.34 | 10.67 | 5.50 | |
| Fixed Turnover | 482.70 | 512.48 | 491.15 | 752.90 | 705.24 | 687.42 | 287.06 | 865.81 | 761.36 | 1,248.32 | 1,279.24 | 462.43 | 352.58 | 327.57 | 189.75 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 233.05 | 66.22 | -1,994.85 | -4,406.67 | -7,019.11 | -33,294.55 | -194,443.48 | -24,448.94 | -9,594.23 | -5,744.49 | 28,440.25 | -1,902.57 | -1,420.69 | -3,969.00 | -7,661.02 | |
| Asset Coverage | 7,300 | 11,400 | 13,100 | 28,900 | 42,500 | 124,600 | 320,500 | 1,553,200 | 12,356,500 | - - | 21,500 | 17,000 | 17,000 | 18,500 | 39,600 | |
| Cash Flow Coverage (CFGR) | 424.73 | -1,491.81 | -1,368.84 | 15,828.15 | 132.82 | -45,242.51 | -99,643.48 | 380,004.76 | -1,633,666.67 | -6,899.08 | 12,640.31 | -1,451.75 | -1,875.82 | -2,285.48 | -4,230.62 | |
| EBITDA Coverage | 1,300 | 900 | -1,200 | 5,600 | -1,100 | -26,600 | -120,400 | -12,100 | -8,800 | -4,400 | 29,900 | -1,700 | -1,100 | -2,700 | 1,900 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | -700 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 1.59 | 1.48 | -12.50 | -1.34 | -2.01 | 7.21 | -6.24 | 1.92 | -3.11 | -0.57 | 1.41 | -5.85 | -3.25 | -8.21 | 10.50 | |
|
Price/Earnings (P/E)
|
6,310.71 | 6,743.67 | -800.31 | -7,471.78 | -4,981.41 | 1,387.33 | -1,603.23 | 5,221.26 | -3,211.67 | -17,589.01 | 7,097.00 | -1,710.10 | -3,074.46 | -1,218.73 | 952.23 | |
| Price/Earnings Growth (PEG) | -52.46 | 314.70 | 0.96 | 90.68 | -182.65 | -2.81 | 3.99 | -38.52 | 10.77 | 231.23 | -12.58 | 6.10 | 46.36 | -11.07 | -4.84 | |
|
Price/Book (P/B)
|
174.47 | 198.44 | 223.76 | 360.89 | 240.79 | 223.52 | 520.11 | 371.70 | 367.20 | 423.83 | 369.81 | 195.60 | 120.07 | 105.17 | 72.11 | |
| Price/Tangible Book (P/TB) | 174.47 | 198.44 | 223.76 | 360.89 | 240.79 | 223.52 | 520.11 | 371.70 | 367.20 | 423.83 | 369.81 | 195.60 | 120.07 | 105.17 | 72.11 | |
| Price/Sales (P/S) | 204.05 | 240.75 | 276.24 | 313.69 | 292.27 | 664.20 | 4,798.40 | 2,177.40 | 2,924.01 | 1,781.76 | 1,258.54 | 1,092.61 | 654.60 | 525.79 | 840.99 | |
|
Price/Cash Flow (P/CF)
|
3,013.68 | -1,586.70 | -2,208.97 | 666.82 | 77,097.38 | -609.81 | -1,656.68 | 1,177.97 | -2,527.40 | -3,612.35 | 331.44 | -1,222.29 | -629.94 | -530.77 | -496.55 | |
| Price/Free CF (P/FCF) | 17,005.57 | -1,291.06 | -1,486.07 | 746.42 | -5,474.74 | -587.99 | -1,565.62 | 1,202.02 | -2,405.71 | -3,295.09 | 336.22 | -1,007.09 | -565.03 | -494.28 | -474.05 | |
| Price/Operating CF (P/OCF) | 3,013.68 | -1,586.70 | -2,208.97 | 666.82 | 77,097.38 | -609.81 | -1,656.68 | 1,177.97 | -2,527.40 | -3,612.35 | 331.44 | -1,222.29 | -629.94 | -530.77 | -496.55 |